New York, August 27, 2023 /PRNewswire/——
Why: ,New York, August 27, 2023.Rosen Law Firm, a global investor rights law firm, reminds investors who purchase the securities of Syneos Health, Inc. (NASDAQ: SYNH ) September 9, 2020 and November 3, 2022including both dates (“class period”), the important September 25, 2023 Lead Plaintiff Deadline.
so what: If you purchased Syneos securities during the Class Period, you may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Syneos Class Action, visit https://rosenlegal.com/submit-form/?case_id=17965 or call Mr Philip King For class action information, call toll-free 866-767-3653 or email email@example.com or Cases@rosenlegal.com. A class action lawsuit has been filed.If you wish to serve as lead plaintiff, you must file a motion with the court Not later than September 25, 2023. A lead plaintiff is a representative party directing litigation on behalf of other class members.
Why choose the Rosen method: We encourage investors to select qualified attorneys with a successful track record in leadership roles. Often, the firms making the notifications do not have similar experience, resources, or any meaningful peer recognition. Many of these firms do not actually file securities class actions, but are merely intermediaries who refer clients or work with the law firms that actually file the lawsuits. Choose advisors wisely. Rosen Law Firm represents global investors with a focus on securities class actions and shareholder derivative actions. Rosen Law Firm reaches the largest-ever securities class action settlement against a Chinese company. Rosen Law Firm was ranked No. 1 by ISS Securities Class Action Services in the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors.In 2019 alone, the company received more than $438 million For investors. 2020, Founding Partner Lawrence Rosen Named a “Plaintiffs’ Bar Association Titan” by law360. Many of our lawyers are accredited by Lawdragon and Super Lawyers.
Case Details: According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose throughout the class period that (1) Syneos’ business development capabilities were compromised by workforce reductions, leadership and operational changes, and labor issues. severely damaged. (2) Syneos has struggled to integrate recent acquisitions, resulting in a bloated and disorganized Syneos organization that impairs Syneos’ ability to provide comprehensive or effective customer engagement across its product portfolio; (3) ) Syneos faces serious competitive disadvantage as clinical trials shift to remote monitoring decentralized
management, as Syneos lacks the tools to successfully run and run remotely that some competitors have decentralized Some experiments, such as certain data visualization and statistical modeling capabilities, Syneos failed to adapt to changing business needs in the wake of the COVID-19 pandemic; (4) Syneos’ backlog, book-to-bill ratio, and net new business incentives were artificially inflated Exceed $500 million By including reimbursable fees that Syneos will never charge; (5) Syneos’ entire customer base is dissatisfied due to difficulties in enforcing existing contracts and responding nimbly to customer needs due to the above; (6) Syneos therefore faces significant future The disclosed risk that Syneos will lose customers, be unable to expand its customer base or win major contract renewals, and cede market share to competitors. When the real details hit the market, the lawsuit says investors lost money.
To join the Syneos Class Action, visit https://rosenlegal.com/submit-form/?case_id=17965 or call Mr Philip King For class action information, call toll-free 866-767-3653 or email firstname.lastname@example.org or Cases@rosenlegal.com.
No categories have been certified. You will not be represented by an attorney until the course is accredited unless you hire an attorney. You can choose the lawyer you like. You can also still have absent class members and do nothing at this point. An investor’s ability to share in any potential future recovery is not contingent on serving as lead plaintiff.
Follow us on LinkedIn for updates: https://www.linkedin.com/company/the-rosen-law-firm and on Twitter: https://twitter.com/rosen_firm Or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer ads. Prior results do not guarantee similar results.
Mr Lawrence Rosen
Mr Philip King
Rosen Law Firm, Pennsylvania
40th Floor, 275 Madison Avenue
New York City, New York 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
View original content Download Multimedia: https://www.prnewswire.com/news-releases/top-ranked-rosen-law-firm-encourages-syneos-health-inc-investors-to-secure-counsel-before-important- Securities Action Deadline – synh-301910416.html
SOURCE: Rosen Law Firm of Pennsylvania
Content provided by PR Newswire. Jinri Toutiao is not responsible for the content provided or any link related to the content. Toutiao is not responsible for the correctness, topicality or quality of the content.